Hims & Hers Health Inc.
Organization details
- Legal name
- Hims & Hers Health Inc.
- Former names
- Oaktree Acquisition Corp.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 8011 — Services-Offices & Clinics of Doctors of Medicine
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- SAN Francisco
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- HIMS
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0001773751
- Wikidata ID
- Q64363662
Board of directors
-
Alex Bard · DirectorSince 2023
-
Ambar Bhattacharyya · DirectorSince 2023
-
Andrew Dudum · Director · Chief Executive OfficerSince 2023
-
Anja Manuel · DirectorSince 2024
-
Christiane Pendarvis · DirectorSince 2023
-
Christopher D. Payne · DirectorSince 2024
-
David B. Wells · DirectorSince 2023
-
Deborah M. Autor · Director · Chief Policy OfficerSince 2024
-
Delos M. Cosgrove · DirectorSince 2023
-
Garcia Andrea G. Perez · DirectorSince 2023
-
Jules A. Maltz · DirectorSince 2023
-
Kare Schultz · DirectorSince 2024
-
Kofi Owusu Amoo-Gottfried · DirectorSince 2026
-
Kristen Green · DirectorSince 2023
-
Lynne Chou O'Keefe · DirectorSince 2023
-
Patrick Harrison Carroll · Director · Chief Medical OfficerSince 2023
Chief executives
Director election results
Annual meeting of June 11, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
98.9%
-
99.1%
-
99.4%
-
99.9%
-
99.9%
-
99.9%
-
99.9%
-
100.0%
Board connections
7 of this board's directors also sit on 11 other boards. 1 is in the same sector.
- via Delos M. Cosgrove
-
Amneal Pharmaceuticals Inc. Same sectorvia Deborah M. Autor
- via Christopher D. Payne
- via Christopher D. Payne
- via Delos M. Cosgrove
- via Christiane Pendarvis
- via Kofi Owusu Amoo-Gottfried
- via Kristen Green
- via David B. Wells
- via Kofi Owusu Amoo-Gottfried
- via David B. Wells
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $1,173,216
- 1 purchase by 1 insider
- Sold, last 12 months
- $19,168,721
- 44 sales by 8 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 28, 2026 | Boughton Soleil Officer (Chief Legal Officer) | Open-market sale | −3,462 | $27.60 | $95,551 |
| Oct 1, 2026 | Okupe Oluyemi Officer (Chief Financial Officer) | Open-market sale | −2,000 | $29.70 | $59,400 |
| Sep 30, 2026 | Boughton Soleil Officer (Chief Legal Officer) | Open-market sale | −3,461 | $29.17 | $100,957 |
| Sep 22, 2026 | Okupe Oluyemi Officer (Chief Financial Officer) | Option exercise | +14,000 | $5.01 | $70,140 |
| Sep 22, 2026 | Okupe Oluyemi Officer (Chief Financial Officer) | Open-market sale | −29,277 | $29.95 | $876,846 |
| Sep 17, 2026 | Okupe Oluyemi Officer (Chief Financial Officer) | Open-market sale | −12,313 | $28.82 | $354,861 |
| Sep 16, 2026 | Boughton Soleil Officer (Chief Legal Officer) | Open-market sale | −6,236 | $27.86 | $173,735 |
| Sep 15, 2026 | Chi Michael Officer (Chief Operating Officer) | Open-market sale | −14,027 | $28.39 | $398,227 |
| Sep 15, 2026 | Mohamed Elshenawy Officer (CTO) | Open-market sale | −7,954 | $28.39 | $225,814 |
| Sep 2, 2026 | Boughton Soleil Officer (Chief Legal Officer) | Open-market sale | −3,458 | $28.33 | $97,965 |
| Aug 27, 2026 | Andrew Dudum Director, Officer (Chief Executive Officer), 10% owner | Other | −977,566 | — | — |
| Aug 25, 2026 | Andrew Dudum Director, Officer (Chief Executive Officer), 10% owner | Gift | −463,289 | — | — |
| Aug 19, 2026 | Boughton Soleil Officer (Chief Legal Officer) | Open-market sale | −25,111 | $27.55 | $691,808 |
| Aug 19, 2026 | Okupe Oluyemi Officer (Chief Financial Officer) | Option exercise | +4,938 | $5.01 | $24,739 |
| Aug 19, 2026 | Okupe Oluyemi Officer (Chief Financial Officer) | Open-market sale | −4,938 | $29.99 | $148,091 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Hims & Hers Health Inc.
Who is the CEO of Hims & Hers Health Inc.?
Andrew Dudum is Hims & Hers Health Inc.'s Chief Executive Officer.
How many directors are on Hims & Hers Health Inc.'s board?
Hims & Hers Health Inc.'s board has 16 directors: Alex Bard, Ambar Bhattacharyya, Andrew Dudum, Anja Manuel, Christiane Pendarvis, Christopher D. Payne, David B. Wells, Deborah M. Autor, Delos M. Cosgrove, Garcia Andrea G. Perez and 6 others.
Are Hims & Hers Health Inc. insiders buying or selling shares?
Over the last 12 months, Hims & Hers Health Inc. insiders bought $1.2 million of shares in 1 purchase and sold $19.2 million of shares in 44 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="hims-hers-health-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.